Both allopurinol and febuxostat carry similar, significant increased risks for hypersensitivity reactions compared with colchicine, according to data published in Annals of the Rheumatic Diseases.

This study involved 3,708 patients with cancer, with an incidence of paclitaxel HSR of 10.11%. An 11-predictor–based Pac-HSR scoring system was developed, involving the following factors: younger age; ...

1 Department of Microbiology & Immunology, The University of Melbourne, Parkville, Victoria 3010, Australia. An increasing number of HLA associations have been observed with drug-hypersensitivity ...

Hypersensitivity reactions to vaccines occur in 1 in 50,000 to 1 in 100,000 doses. Most are local reactions and allow for the completion of the vaccination series. Systemic reactions are a minority ...

Carlsson and Möller, 1989 20 18 Metal allergic patients, screened before receiving stainless steel orthopedic implants. None had issues despite confirmed allergy to ...